Healthcare -
Biotechnology - NASDAQ - US
$ 6.27
0.642 %
$ 428 M
Market Cap
-3.15
P/E
EYPT - COST OF REVENUE
Cost of Revenue EYPT - EyePoint Pharmaceuticals, Inc.
4.63 M
LAST VALUE
-24.74%
2 YEAR CAGR
-24.19%
5 YEAR CAGR
-7.00%
10 YEAR CAGR